Intended Use: Supplied strictly for laboratory research use only. Not for human consumption or clinical use.
Storage: Keep lyophilized material in a cool, dry place protected from light. After reconstitution, store at 2-8 C when applicable.
Handling: Use appropriate aseptic laboratory technique and validated reconstitution conditions. Consult the batch COA and SDS before use.
Research focus: FOXO4-DRI has been investigated in cellular and animal models involving senescent-cell viability, p53 signaling, and age-associated tissue homeostasis.
Evidence remains preclinical. This product is supplied strictly for research use only.
FOXO4-DRI is designed to interfere with the interaction between FOXO4 and p53 in senescent cells. Preclinical research evaluates whether releasing p53 from this interaction can restore apoptosis signaling in selected senescent-cell models.
FOXO4-DRI is an all-D retro-inverso research peptide studied in preclinical senescence models for its ability to disrupt the FOXO4-p53 interaction.
Contact online support for real-time help with product selection, bulk orders, shipping, or payment.
Key answers before shipping, dispatch, and after-sales details.
Worldwide delivery in 8–15 days with air dispatch on business days.
Tracking provided on every order.
Invalid test results → Full refund.
Dedicated support team with clear pre- and post-payment updates.
Brazil orders require CPF/CNPJ for local tax handling.
Contact our online support for real-time communication about products, orders, shipping, payment, or bulk supply.
